Evaluating the potential mechanism and efficacy of shodhana-rasayana in comparison with Diabetic Specific Diet and Lifestyle modifications in the management of Madhumeha (Diabetes Mellitus Type 2)on fecal metagenomics - An in-silico and randomized comparative clinical study

All India Institute of Ayurveda, CoE TRISUTRA CSIR IGIB0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•Patients diagnosed with Diabetes Mellitus according to WHO criteria
•Subjects diagnosed for Madhemha based on general diagnostic criteria according to document of Protocol for Prevention and Control of Diabetes through Ayurveda, MoA, Page no 37, 2016
•Recently diagnosed (0-5 years) patients who are not on OHA (both overweight/obese and normal BMI â?? ICMR Asian criteria #)
•Subjects of either gender aged more than 18 years, <60 yrs.
•Willingness to consent to randomization

•Emergency cases of diabetes or under immediate consideration for hospitalization and Type 1 DM or Insulin-dependent
•Patient with inflammatory bowel disease Crohns disease or ulcerative colitis, chronic diarrhoea or malabsorption Hepatitis etc
•Patient with a history of other complications with DM
•Female patient who is pregnant, or breast feeding or is considering becoming pregnant during the study or for 6 months after the last dose of study medication
•Patients having known hypersensitivity to any of the proposed trial drug
•Currently under any other trial

发起方

All India Institute of Ayurveda, CoE TRISUTRA CSIR IGIB